January 2, 2018 Sophia Vida
Biotech & Pharma

Trevena Soars on FDA News Over Opioid Replacement Pain Killer

Trevena shares were on fire in after hours trading on Tuesday after the biotech company announced that the Food and Drug Administration has accepted for review a new drug application (NDA) of the company’s opioid-replacement painkiller, Olinvo. Shares were up as much as 25% after Wall Street got wind of the enws. The FDA is … Continue reading “Trevena Soars on FDA News Over Opioid Replacement Pain Killer”